Video

Dr. Salani on Updates in Treating Endometrial Cancer

Author(s):

Ritu Salani, MD, MBA, discusses updates in treating endometrial cancer.

Ritu Salani, MD, MBA, director, Division of Gynecologic Oncology, professor, Obstetrics and Gynecology, University of California, Los Angeles, Jonsson Comprehensive Cancer Center, discusses updates in treating endometrial cancer.

Immunotherapy has changed the treatment landscape of endometrial cancer and studies are evaluating approaches in the recurrence setting as well as the frontline setting, Salani says. Although trials are still being finalized and reviewed, the current results that have been seen with immunotherapy in this patient population is promising, Salani explains.

Moreover, molecular profiling is being utilized more often to inform treatment strategies in endometrial cancer, leading to more personalized medicine in the disease, Salani continues. Looking at the molecular mutations will continue to lead to the understanding of what therapies may best serve patients, Salani says. Some patients may be able to have therapy eliminated or deescalated, further eliminating unwanted toxicities and producing more favorable outcomes, Salani concludes.

Related Videos
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
J. Bradley Elder, MD
Rimas V. Lukas, MD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Shubham Pant, MD, MBBS
Kevin Kalinsky, MD, MS, professor, Department of Hematology and Medical Oncology, director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Louisa and Rand Glenn Family Chair in Breast Cancer Research, director, Glenn Family Breast Center, director, Breast Medical Oncology, Winship Cancer Institute of Emory University
Brett L. Ecker, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center